Shares of health-care companies rose as traders positioned for further deal making in the wake of reported negotiations between major hospital chains. French drug giant Sanofi received Food and Drug Administration approval for commercialization of a mealtime insulin injection. Indian drug maker Dr Reddy rose after the FDA cleared one of the facilities whose manufacturing practices had been under review.
Continue Reading Below
-Rob Curran, firstname.lastname@example.org
(END) Dow Jones Newswires
December 12, 2017 16:18 ET (21:18 GMT)